Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over time von Thomson, Sasha, Witzke, Noah, Gyawali, Bishal, Delos Santos, Seanthel, Udayakumar, Suji, Cardone, Claudia, Cheung, Matthew C., Chan, Kelvin K.W.

Volltext

Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis von Udayakumar, Suji, Parmar, Ambica, Leighl, Natasha B., Everest, Louis, Arciero, Vanessa S., Santos, Seanthel Delos, Rahmadian, Amanda, Doherty, Mark K., Chan, Kelvin K.W.

Volltext

Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis von Parmar, Ambica, Chaves-Porras, Jorge, Saluja, Ronak, Perry, Kaitlyn, Rahmadian, Amanda P., Santos, Seanthel Delos, Ko, Yoo-Joung, Berry, Scott, Doherty, Mark, Chan, Kelvin K.W.

Volltext

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life A Systemati... von Arciero, Vanessa, Delos Santos, Seanthel, Koshy, Liza, Rahmadian, Amanda, Saluja, Ronak, Everest, Louis, Parmar, Ambica, Chan, Kelvin K. W.

Volltext

Examining the association between oncology drug clinical benefit and the time to public reimbursement von Thomson, Sasha, Everest, Louis, Witzke, Noah, Jiao, Tina, Delos Santos, Seanthel, Nguyen, Vivian, Cheung, Matthew C., Chan, Kelvin K. W.

Volltext

Assessing the real-world (RW) efficacy and toxicity of docetaxel (D) for the treatment of metastatic castrate sensitive prostate cancer (mCSPC): A single institution experience von Delos Santos, Seanthel, Phillips, Cameron, Emmenegger, Urban

Volltext

A survey to determine patients’ (pts) opinions of a clinical trial (CT) comparing intermittent (int) versus continuous (cont) androgen receptor signaling inhibitor (ARSi) therapy f... von Phillips, Cameron, Delos Santos, Seanthel, Mason, Robert, Emmenegger, Urban

Volltext

Reassessing the net health benefit (NHB) of FDA approved cancer drugs with evolution of evidence using the American Society of Clinical Oncology Value Framework (ASCO-VF) von Delos Santos, Seanthel, Witzke, Noah, Arciero, Vanessa Sarah, Rahmadian, Amanda Putri, Everest, Louis, Chan, Kelvin K.

Volltext

Examining the relationship between the clinical benefit of oncology drug indications and the time from pan-Canadian Oncology Drug Review (pCODR) recommendation to public reimbursem... von Thomson, Sasha, Everest, Louis, Witzke, Noah, Delos Santos, Seanthel, Cheung, Matthew C., Chan, Kelvin K.

Volltext

Pembrolizumab alone or with chemotherapy for PD-L1 positive NSCLC: A network meta-analysis of randomized trials von Doherty, Mark, Delos Santos, Seanthel, Rahmadian, Amanda Putri, Everest, Louis, Chan, Kelvin K.

Volltext

Development of a predictive model of PSA response to a switch from prednisone to dexamethasone in metastatic castrate-resistant prostate cancer patients biochemically progressing o... von Barua, Reeta, Phillips, Cameron, Arciero, Vanessa Sarah, Zhang, Liying, Rahmadian, Amanda, Delos Santos, Seanthel, Parshad, Shruti, Emmenegger, Urban

Volltext

Immunotherapy (IO) versus non-IO for oncology drugs: Comparing survival benefits (SB) using restricted mean survival time von Rahmadian, Amanda Putri, Delos Santos, Seanthel, Parshad, Shruti, Everest, Louis, Cheung, Matthew C., Chan, Kelvin K.

Volltext

A network meta-analysis of adjuvant systemic therapy in resected pancreatic cancer von Chaves Porras, Jorge, Perry, Kaitlyn, Putri Rahmadian, Amanda, Delos Santos, Seanthel, Ko, Yoo-Joung, Berry, Scott R., Doherty, Mark, Chan, Kelvin K.

Volltext